NCT04560673View on ClinicalTrials.gov

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

July 10, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chemotherapy-Induced Peripheral NeuropathyHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
DRUG

Duloxetine

Given PO

BEHAVIORAL

Neurofeedback

Receive neurofeedback training

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

77026

RECRUITING

Harris Health System (LBJ), Houston

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER